Evidence map›Paper›PMID 12902981›Full record

ArticleOncogene2003

Repression of MUC2 gene expression by butyrate, a physiological regulator of intestinal cell maturation.

Leonard Augenlicht, Li Shi, John Mariadason, Christian Laboisse, Anna Velcich

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 67 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. The Role of Short Chain Fatty Acids in Irritable Bowel Syndrome.Journal of neurogastroenterology and motility · 2022
    Review
  6. Review
  7. Article
  8. Review
  9. Regulation of SIRT2 by Wnt/β-catenin signaling pathway in colorectal cancer cells.Biochimica et biophysica acta. Molecular cell research · 2021
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. EVALUATION OF ENEMAS CONTAINING SUCRALFATE IN TISSUE CONTENT OF MUC-2 PROTEIN IN EXPERIMENTAL MODEL OF DIVERSION COLITIS.Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery · 2018
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Leonard AugenlichtDepartment of Oncology, Albert Einstein Cancer Center/Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467, USA.
Li Shi
John Mariadason
Christian Laboisse
Anna Velcich
Albert Einstein College of Medicine · USMontefiore Medical Center · USInserm · FR

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI THOMAS E ROHAN · 1985 to 2026
$111.2M
Inactivation of the Muc2 gene and colorectal cancerR01CA090808 · NCI · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI VELCICH, ANNA · 2001 to 2005
$1.1M
COLON CELL DIFFERENTIATION--DCC ROLE IN MUC2 EXPRESSIONR01CA068965 · NCI · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI AUGENLICHT, LEONARD H. · 1996 to 2000
$196k
NCI NIH HHS CA-68965NCI NIH HHS CA-90808NCI NIH HHS P30CA-13330
6 · The paper itself

Abstract

Sodium butyrate (NaB) inhibits proliferation, stimulates apoptosis, and promotes differentiation of human colon cancer cells along the absorptive phenotype. In vitro, butyrate induces a switch from cells with a secretory to an absorptive phenotype. Here, we report that NaB specifically represses the expression of the MUC2 gene, a differentiation marker of the secretory goblet cell lineage, in forskolin- and 12-O-tetradecanoylphorbol 13-acetate-induced HT29 cells, and Cl.16E cells, a clonal derivative of HT29 cells that spontaneously differentiates into goblet cells. Thus, NaB repression is independent of the nature of the stimulus that triggers MUC2 expression. Further, repression was independent of new protein synthesis. Our results suggest that inhibition of MUC2 is linked to the ability of butyrate to repress histone deacetylase activity, since trichostatin A, another inhibitor of histone deacetylases, also inhibited MUC2 expression in induced HT29 cells. Finally, we demonstrate that the NaB effect is specific for this marker of the secretory cell lineage, since carcinoembryonic antigen, which is expressed in both the secretory and absorptive cells, is induced by NaB. Thus, the NaB repression of a definitive function of the secretory cell lineage is a further mechanism, in addition to the effects on proliferation and apoptotic pathways, through which butyrate can regulate intestinal homeostasis.

Indexed as

ButyratesCell DifferentiationGene Expression RegulationHumansHydroxamic AcidsMitogen-Activated Protein KinasesMucin-2MucinsProtein Synthesis InhibitorsButyratesHydroxamic AcidsMitogen-Activated Protein KinasesMUC2 protein, humanMucin-2MucinsProtein Synthesis Inhibitorstrichostatin A

Identifiers

PMID12902981
OpenAlexW2148682389

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.